Shanghai Shenqi Pharmaceutical Investment Management Co Ltd banner

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
SSE:600613

Watchlist Manager
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd Logo
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
SSE:600613
Watchlist
Price: 6.2 CNY 0.98% Market Closed
Market Cap: ¥3.3B

Balance Sheet

Balance Sheet Decomposition
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd

Balance Sheet
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
28
9
8
40
6
11
3
5
14
27
23
31
328
297
264
309
284
206
596
482
494
655
714
779
Cash
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
0
1
0
0
494
655
714
779
Cash Equivalents
28
9
8
40
6
11
3
5
14
27
23
31
326
296
263
309
284
205
596
481
0
0
0
0
Short-Term Investments
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21
21
Total Receivables
85
20
23
105
89
99
108
94
110
83
113
431
676
853
1 120
1 221
1 252
1 259
1 092
712
714
829
764
538
Accounts Receivables
20
5
9
63
49
51
58
51
46
32
40
131
338
503
644
852
913
870
776
487
455
361
393
323
Other Receivables
64
16
15
42
39
49
50
43
64
51
73
300
339
350
476
368
339
390
315
225
258
467
370
215
Inventory
4
18
15
14
10
6
5
5
4
5
10
53
85
151
174
208
208
175
161
204
205
219
243
228
Other Current Assets
0
0
0
1
1
9
16
5
3
1
0
4
26
89
36
146
83
98
31
34
33
68
31
29
Total Current Assets
117
47
46
160
106
125
133
109
129
116
146
518
1 115
1 389
1 593
1 884
1 827
1 739
1 879
1 431
1 446
1 770
1 772
1 596
PP&E Net
21
54
43
141
134
126
118
108
100
92
84
151
335
371
430
465
556
688
825
960
1 167
1 105
1 056
1 062
PP&E Gross
21
54
43
141
134
126
118
108
100
92
84
151
335
371
430
465
556
688
825
960
1 167
1 105
1 056
1 062
Accumulated Depreciation
8
11
9
23
33
42
52
61
72
81
90
208
265
295
328
368
403
428
463
506
588
672
750
822
Intangible Assets
4
9
8
43
38
32
32
32
0
0
0
10
109
56
108
113
121
125
118
111
105
99
95
97
Goodwill
0
0
0
0
0
0
0
0
0
0
0
0
412
412
412
412
461
461
461
299
299
299
244
244
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
0
0
0
Long-Term Investments
171
127
118
17
17
10
11
11
11
11
11
11
22
23
121
120
113
96
82
94
92
75
82
93
Other Long-Term Assets
96
85
75
0
0
1
1
2
4
2
2
2
3
4
8
11
17
19
191
203
31
38
30
25
Other Assets
0
0
0
0
0
0
0
0
0
0
0
0
412
412
412
412
461
461
461
299
299
299
244
244
Total Assets
409
N/A
322
-21%
290
-10%
361
+24%
295
-18%
295
N/A
295
0%
262
-11%
244
-7%
221
-10%
243
+10%
691
+184%
1 995
+189%
2 254
+13%
2 671
+19%
3 003
+12%
3 096
+3%
3 127
+1%
3 556
+14%
3 098
-13%
3 149
+2%
3 386
+8%
3 279
-3%
3 116
-5%
Liabilities
Accounts Payable
7
3
3
21
6
7
8
7
5
3
5
31
60
73
103
95
138
181
163
151
188
187
250
224
Accrued Liabilities
20
28
50
24
34
16
22
10
17
14
0
0
26
27
59
66
49
40
36
24
32
61
36
34
Short-Term Debt
129
99
74
90
36
59
40
20
20
0
0
79
0
30
42
109
130
0
130
3
105
351
258
100
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
37
1
0
0
0
0
0
0
25
45
44
48
50
Other Current Liabilities
2
13
12
49
34
23
21
16
16
11
26
30
95
124
153
276
230
266
254
255
110
132
94
123
Total Current Liabilities
157
143
140
183
110
105
90
53
58
29
32
177
181
254
358
546
546
487
584
457
480
774
686
531
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
30
0
0
0
0
0
0
239
286
258
220
187
140
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26
20
17
12
16
16
16
18
14
16
Minority Interest
10
10
10
17
18
18
19
20
18
19
20
22
26
32
56
76
67
59
45
50
48
45
55
64
Other Liabilities
0
0
0
2
0
0
0
0
0
0
0
0
2
2
2
2
3
28
56
11
3
2
1
2
Total Liabilities
167
N/A
154
-8%
150
-2%
202
+34%
127
-37%
124
-3%
109
-12%
73
-34%
76
+4%
47
-38%
52
+10%
229
+342%
210
-8%
288
+37%
441
+53%
644
+46%
633
-2%
587
-7%
939
+60%
821
-13%
805
-2%
1 059
+32%
944
-11%
753
-20%
Equity
Common Stock
148
148
148
148
148
148
148
148
148
148
148
148
445
445
534
534
534
534
534
534
534
534
534
534
Retained Earnings
46
120
148
162
5
1
13
17
4
2
20
171
282
462
651
797
911
1 001
1 085
744
813
808
811
829
Additional Paid In Capital
141
141
141
174
24
24
24
24
24
24
24
144
1 058
1 058
969
969
969
969
969
969
969
969
969
969
Unrealized Security Profit/Loss
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16
21
31
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
76
58
49
36
29
31
28
16
0
0
Total Equity
242
N/A
168
-31%
140
-17%
159
+14%
167
+5%
171
+2%
185
+8%
189
+2%
168
-11%
174
+3%
191
+10%
463
+142%
1 786
+286%
1 966
+10%
2 230
+13%
2 359
+6%
2 463
+4%
2 540
+3%
2 617
+3%
2 277
-13%
2 344
+3%
2 327
-1%
2 335
+0%
2 363
+1%
Total Liabilities & Equity
409
N/A
322
-21%
290
-10%
361
+24%
295
-18%
295
N/A
295
0%
262
-11%
244
-7%
221
-10%
243
+10%
691
+184%
1 995
+189%
2 254
+13%
2 671
+19%
3 003
+12%
3 096
+3%
3 127
+1%
3 556
+14%
3 098
-13%
3 149
+2%
3 386
+8%
3 279
-3%
3 116
-5%
Shares Outstanding
Common Shares Outstanding
178
178
178
178
178
178
178
178
178
178
178
300
534
534
534
534
534
534
534
534
534
534
534
534
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett